Minerva specializes in quality investigations, product development, and productivity improvement in the cell and gene therapy, biotech vaccines, and medical devices industries. We integrate advanced digitalization, visualization, and knowledge and risk management techniques to deliver exceptional results.
The Minerva Way
The Minerva Way is the process we use to assist, collaborate, and deliver digitalized, highly visual, data-driven risk and knowledge-based solutions to our partners in the Life Science Industry.
The central principle of “Time is Life” is how we conduct ourselves to make possible our vision of keeping patients’ hope alive.
Since Process Automation and Rapid QC are fundamental to achieving Life Sciences goals, we have developed the capabilities necessary to support the industry on the automation solutions available to increase productivity, quality, and timeliness.
Integrated digitalization and visuals ensure that knowledge transfer and risk-based controls are efficient and Right First Time. The result is a fast and quality-based product development, commercialization, and continuous improvement.
Our Capabilities
Technical Analysis, Visualization, and Digitalization
Minerva provides accurate technical analysis, visualization, and digitalization for life sciences products and processes in the discovery phase. The use of technical images, models, and infographics facilitates multidisciplinary collaboration and improvements. The resulting information is organized in databases to facilitate the identification of
risks and their mitigations.
Process Modeling with Database Integration
In the process development phase, Minerva models the physical, chemical and biological interactions, in both, visual and database formats, to allow the analysis
and improvement by people, software and artificial intelligence.
Definition of Machine Learning Requirements for Automation
Minerva collaborates with the Life Science industry using our knowledge and
risk management capabilities to identify machine learning modules and the data needed to model and train AI-driven systems.
Manufacturing Data Analysis for Continuous Improvement and Innovation
Minerva digitalizes manufacturing procedures, records, and operational experiences; enriches them with visuals, and uses them for improved risk mitigation meetings. This methodology provides the pathway for improved collaboration and the control of design, process, and usability risks.
Expedited Risk-based Investigation Resolution and Reduction
Minerva provides on-site and virtual quality investigation teams combining
multi-disciplinary capabilities supported by development scientists, engineers,
and visualization experts. We diagnose and correct manufacturing issues before,
or as soon as they occur, producing better corrective and preventive actions.
Quality Investigations
Data-driven and Knowledge-based Manufacturing Optimization
Optimization is critical to increasing capacity. By interpreting the data we collect, Minerva partners with life sciences companies to optimize their manufacturing processes, thereby increasing their capacity and productivity.
Continuous Agility in Product Knowledge and Improvements
Another service Minerva provides companies seeking to increase their capacity is the continual development of product knowledge to drive improvements. This is the sustained, long-term study of the company’s product and its potential so it can be routinely upgraded or innovated.
Robotic Medical Devices for Treatment, Manufacturing, and Diagnostics
Minerva participates in the development and commercialization of robotic
medical devices. We use digitalized, highly visual risk management, configuration management, and traceability databases to facilitate collaboration among teams and accelerate Time-to-Market.
Minerva’s Bay Area product development laboratory supports our product characterization and quality investigation efforts through wet-lab scientific studies, high-end optical measurements, and robotic prototypes.
